| 产品描述: | BIBO3304 TFA is a potent, orally active, and selective neuropeptide Y (NPY) Y1 receptor antagonist, with subnanomolar affinity for both the human and the rat Y1 receptor (IC50=0.38 and 0.72 nM, respectively) |
| 靶点: |
Neuropeptide Y Receptor |
| 体外研究: |
BIBO3304 TFA (30 μg; bilateral paraventricular nucleus injection) attenuates the hyperphagia following fasting. BIBO3304 TFA (15-60 μg) dose-dependently inhibits the feeding reponse mediated by 1 μg NPY. BIBO3304 TFA (0.5 μM; p.o.) significantly increases serum insulin levels. Animal Model: Adult male Chbb:Thom rats weighing between 300 and 340g Dosage: 30 μg Administration: bilateral paraventricular nucleus injection Result: Attenuated the hyperphagia following fasting, especially during the first 2 h of refeeding. Animal Model: 7-week-old C57BL/6JAusb mice Dosage: 0.5 μM Administration: p.o. Result: Significantly increased serum insulin levels. |
| 参考文献: |
1. Wieland HA, et al. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br J Pharmacol. 1998 Oct;125(3):549-55. 2. Loh K, et al. Inhibition of Y1 receptor signaling improves islet transplant outcome. Nat Commun. 2017 Sep 8;8(1):490. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.554 ml |
7.768 ml |
15.536 ml |
| 5 mM |
0.311 ml |
1.554 ml |
3.107 ml |
| 10 mM |
0.155 ml |
0.777 ml |
1.554 ml |
| 50 mM |
0.031 ml |
0.155 ml |
0.311 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |